- Home
- TLSI vs MRT Comparison
TLSI vs MRT Comparison
Compare TLSI & MRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- MRT
- Stock Information
- Founded
- TLSI 2010
- MRT 2018
- Country
- TLSI United States
- MRT Turkey
- Employees
- TLSI N/A
- MRT N/A
- Industry
- TLSI Medical Specialities
- MRT Rental/Leasing Companies
- Sector
- TLSI Health Care
- MRT Consumer Discretionary
- Exchange
- TLSI Nasdaq
- MRT Nasdaq
- Market Cap
- TLSI 158.0M
- MRT 181.8M
- IPO Year
- TLSI N/A
- MRT N/A
- Fundamental
- Price
- TLSI $5.77
- MRT $3.45
- Analyst Decision
- TLSI Strong Buy
- MRT
- Analyst Count
- TLSI 6
- MRT 0
- Target Price
- TLSI $11.75
- MRT N/A
- AVG Volume (30 Days)
- TLSI 40.4K
- MRT 41.3K
- Earning Date
- TLSI 03-27-2025
- MRT 01-01-0001
- Dividend Yield
- TLSI N/A
- MRT N/A
- EPS Growth
- TLSI N/A
- MRT N/A
- EPS
- TLSI N/A
- MRT N/A
- Revenue
- TLSI $26,891,000.00
- MRT $18,953,502.00
- Revenue This Year
- TLSI $61.29
- MRT N/A
- Revenue Next Year
- TLSI $53.21
- MRT $101.81
- P/E Ratio
- TLSI N/A
- MRT N/A
- Revenue Growth
- TLSI 67.90
- MRT N/A
- 52 Week Low
- TLSI $3.50
- MRT $0.71
- 52 Week High
- TLSI $10.42
- MRT $3.89
- Technical
- Relative Strength Index (RSI)
- TLSI 68.94
- MRT 55.09
- Support Level
- TLSI $5.40
- MRT $2.86
- Resistance Level
- TLSI $5.82
- MRT $3.70
- Average True Range (ATR)
- TLSI 0.24
- MRT 0.23
- MACD
- TLSI 0.01
- MRT 0.03
- Stochastic Oscillator
- TLSI 89.19
- MRT 70.36
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About MRT Marti Technologies Inc.
Marti Technologies Inc is a mobility app, operating a fleet of over 48,000 e-mopeds, e-bikes, and e-scooters, serviced by proprietary software systems and IoT infrastructure.